aChE and BuChE inhibition by rivastigmin have no effect on peripheral insulin resistance in elderly patients with Alzheimer disease
- 123 Downloads
Insulin resistance (IR) may play a role in most pathogenic processes that promote the development of Late Onset Alzheimer Disease (LOAD). This study was designed to determine the interaction between inhibition of both butyrylcholinesterase (BuChE) and acetylcholinesterase (AChE) with rivastigmine and peripheral insulin resistance (IR) in LOAD.
Seventy-Nine consecutive elderly patients, 31 late onset AD and 48 non-demented patients were evaluated. IR was calculated with HOMA. All of the patients were evaluated through comprehensive geriatric assessments at baseline and in the 6th and 12th months.
End of the study, compared to the baseline values, there was a significant increase in the 6th month in both MMSE and IADL scores (t =2.200, p = 0.036 for MMSE and t =2.724, p= 0.011 for IADL, respectively). Rivastigmine was improved both the scores of MMSE and IADL in elderly patients with LOAD, but there was no significance or correlation between HOMA scores and cognitive status.
In conclusion, inhibition of both BuChE and AChE with rivastigmine was improved the cognition without affecting on the peripheral IR in the elderly patients with LOAD by HOMA. Due to the complexity of disease pathogenesis, it is too early to make general comments, and further longitudinal and long-term studies on this issue are needed.
Key wordsInsulin resistance rivastigmine Alzheimer disease elderly
Unable to display preview. Download preview PDF.
- 1.Isik AT, Bozoglu E: Insulin Resistance In Alzheimer Disease: Eds: Aucoin L, Prideux T: Handbook of Type 1 Diabetes Mellitus: Etiology, Diagnosis, and Treatment, Nova Science, Hauppauge NY, 2010 (ISBN: 978-1-60741-311-0).Google Scholar
- 15.Isik AT, Bozoglu E, Naharci MI, Eker D: Cardiac Safety of Rivastigmine in Patients with Late Onset Alzheimer’s Disease. Journal of Geriatrics and Geriatric Neuropsychiatry, 2010;1(3): 21–26.Google Scholar
- 17.Stolk RP, Breteler MM, Ott A et al: Insulin and cognitive function in elderly population. The Rotterdam Study. Diabetes Care, 1997;20:792–795.Google Scholar
- 19.Ho L, Qin W, Pompl PN et al: Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer’s disease. The FASEB Journal, 2004;18:902–904.Google Scholar
- 20.Reyes AE, Chacón MA, Dinamarca MC, Cerpa W, Morgan C, Inestrosa NC: Acetylcholinesterase-Abeta complexes are more toxic than Abeta fibrils in rat hippocampus: effect on rat beta-amyloid aggregation, laminin expression, reactive astrocytosis, and neuronal cell loss. Am J Pathol, 2004;164:2163–2174.PubMedCrossRefGoogle Scholar